2616.HK
2616.HK
KYG2588M1006
CSTONE PHARMA-B
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 269.583.000 407.205.000
33.8%
Cost of Revenue 218.336.000 167.051.000
30.7%
Gross Profit 51.247.000 240.154.000
78.7%
468.742.000 331.846.000
41.3%
Operating Income -417.495.000 -91.692.000
355.3%
Pretax Income -423.939.000 -91.207.000
364.8%
Net Income Common Stockholders -437.003.000 -91.207.000
379.1%
-- --
--
-- --
--
ende